Related Experiment Video
Updated: Jul 9, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi
Pierre I Karakiewicz1, Nazareno Suardi, Claudio Jeldres
1Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada. pierre.karakiewicz@umontreal.ca <pierre.karakiewicz@umontreal.ca>
Abstract:
A 75-yr-old previously healthy woman presented with gross hematuria, European Cooperative Oncology Group 0, and an 11-cm renal mass with right atrial thrombus. The patient refused the sternotomy. She was offered two cycles of sunitinib maleate (Sutent) induction therapy to down-stage the thrombus and to reduce the extent of the surgery.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Antihypertensive Drugs: Direct Renin Inhibitors
